MSDC-0160 Uses, Dosage, Side Effects and more
MSDC-0160 has been used in trials studying the treatment of Type 2 Diabetes and Alzheimer's Disease.
| Attribute | Details |
|---|---|
| Trade Name | MSDC-0160 |
| Generic | Mitoglitazone |
| Mitoglitazone Other Names | MSDC-0160 |
| Type | |
| Formula | C19H18N2O4S |
| Weight | Average: 370.422 Monoisotopic: 370.098727764 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
